Purdue Pharma LP

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Jun 1, 2023TrialClinical Outcomes From Nalmefene

May 9, 2023FDAAmbien — ZOLPIDEM TARTRATE

Oct 3, 2022TrialPharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

Aug 3, 2021TrialSafety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Jul 30, 2020TrialReal-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Mar 14, 2017TrialA Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the Knee

Jan 1, 2017TrialSafety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children

Aug 1, 2016TrialA Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

4 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Ambien2 patentsApr 6, 2027 AmbienAug 20, 2029 AmbienFeb 25, 2031 AmbienAug 7, 2032

Regulatory

Regulatory Timeline

19921 event

FDADec 16

Ambien — AMBIEN

Application NDA019908 (NDA)

19991 event

FDAAug 5

Chirocaine — CHIROCAINE

Application NDA020997 (NDA)

20051 event

FDASep 2

Ambien — AMBIEN CR

Application NDA021774 (NDA)

20071 event

FDAApr 25

Ambien — TOVALT ODT

Application NDA021412 (NDA)

20081 event

FDADec 19

Ambien — ZOLPIMIST

Application NDA022196 (NDA)

20091 event

FDAMar 13

Ambien — EDLUAR

Application NDA021997 (NDA)

20111 event

FDANov 23

Ambien — INTERMEZZO

Application NDA022328 (NDA)

20231 event

FDAMay 9

Ambien — ZOLPIDEM TARTRATE

Application NDA215721 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)